CC
Chandan Chopra
About Chandan Chopra
Data last updated:
Chandan Chopra is a Director at Zymes Bioscience Private Limited (since 2024), Designated Partner at Awake Life Sciences Llp (since 2018) and Director at Astrom Bioscience Private Limited (since 2012), and holds 2 more current directorships. The companies operate in Pharma, Healthcare and Business Services. The 3 current companies with reported revenue have a combined latest revenue of ₹73.10 Cr; the largest is Zymes Bioscience Private Limited at ₹49.64 Cr (FY 2025). Earlier, Chandan Chopra was a Director at Swizinger Health Care Private Limited (2008–2009) and Director at Saiman Life Sciences Private Limited (2018–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 May 2024 | 2012 | ₹49.64 Cr (FY 2025) | Active | |
| Designated Partner | 24 May 2018 | 2015 | ₹23.45 Cr (FY 2023) | Active | |
| Director | 23 Feb 2012 | 2012 | ₹42,180 (FY 2016) | Active | |
| Designated Partner | 13 Jan 2026 | 2026 | Active | ||
| Director | 06 Aug 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Sep 2008 | 2008 | Active | ||
| Director | 08 Jan 2018 | 2018 | ₹1.26 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Chandan Chopra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shivali Choudhary | 08125556 | Zymes Bioscience Private Limited | Director |
| Binny Chopra | 07072747 | Awake Life Sciences Llp | Designated Partner |
| Deepak Chawla | 11480750 | Core Technomed Llp | Designated Partner |
| Falak | 11480749 | Core Technomed Llp | Designated Partner |
| Rahul Chhabra | 11480751 | Core Technomed Llp | Designated Partner |
| Aniket Dhingra | 08660951 | Zymes Tech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chandan Chopra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chandan Chopra
Chandan Chopra currently holds 5 directorships: Zymes Bioscience Private Limited (Director, since 01 May 2024, revenue ₹49.64 Cr (FY 2025)); Awake Life Sciences Llp (Designated Partner, since 24 May 2018, revenue ₹23.45 Cr (FY 2023)); Astrom Bioscience Private Limited (Director, since 23 Feb 2012, revenue ₹42,180 (FY 2016)); Core Technomed Llp (Designated Partner, since 13 Jan 2026); Zymes Tech Private Limited (Director, since 06 Aug 2020).
Chandan Chopra was first appointed on 15 Sep 2008 as Director at Swizinger Health Care Private Limited. The most recent appointment on record is 13 Jan 2026 at Core Technomed Llp.
The 3 current companies of Chandan Chopra that report revenue have a combined latest revenue of ₹73.10 Cr: Zymes Bioscience Private Limited ₹49.64 Cr (FY 2025); Awake Life Sciences Llp ₹23.45 Cr (FY 2023); Astrom Bioscience Private Limited ₹42,180 (FY 2016).
Chandan Chopra held 2 earlier board appointments: Swizinger Health Care Private Limited (Director, 15 Sep 2008 to 30 Sep 2009); Saiman Life Sciences Private Limited (Director, 08 Jan 2018 to 20 Feb 2022).
The current boards of Chandan Chopra's companies include Shivali Choudhary (Zymes Bioscience Private Limited), Binny Chopra (Awake Life Sciences Llp), Deepak Chawla (Core Technomed Llp), Falak (Core Technomed Llp), Rahul Chhabra (Core Technomed Llp), Aniket Dhingra (Zymes Tech Private Limited).